Translation of a questionnaire to self assess voice problems in transwomen from English to Malayalam. .
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: F640- Transsexualism
- Registration Number
- CTRI/2019/08/020876
- Lead Sponsor
- Ayisha Shoukheen K
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) People who were born as a male but are now leading a lifestyle of female for a minimum of 2 years; Trans gender male to female.
2) Both transsexuals and transgenders will be considered for the study.
3) Participants should be adults.
4) Literate in the Malayalam language.
Exclusion Criteria
1) Trans genders below the age of 18.
2) Trans women diagnosed with severe psychiatric disorders and who are under medication for the same.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The internal consistency and the test retest reliability of the translated Malayalam Transsexual Voice Questionnaire (MtF).Timepoint: 01-09-2019 TO 30-05-2020
- Secondary Outcome Measures
Name Time Method ATimepoint: NA
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie voice changes in transsexualism (F640) and how can they be targeted for assessment tools?
How does the Malayalam-translated male to female Transsexual Voice Questionnaire compare to standard voice assessment tools in transwomen?
Are there specific biomarkers associated with voice dysphoria in transsexual individuals that can improve patient selection for voice evaluation?
What adverse events are commonly reported in transwomen undergoing voice assessment and how can they be managed effectively?
What are the current drug classes or combination therapies being explored for voice modulation in transsexualism (F640) and how does this trial contribute to the field?